-+ 0.00%
-+ 0.00%
-+ 0.00%

NEKTAR THERAPEUTICS - JURY AWARDS NEKTAR THERAPEUTICS $90 MLN IN DAMAGES PLUS INTEREST - SEC FILING

Reuters·09/25/2026 11:03:26